Noveris Health Sciences is trading 5.88% lower at CA$0.08, with no company-specific announcement identified to explain the September 29, 2026 decline.
- The latest listed company release is the September 9 annual-meeting results.
- Reuters reported cautious broader risk sentiment on September 29 as oil prices rose and bond yields remained near multi-year highs, pressuring global equities. Available evidence does not establish these concerns as the direct cause of Noveris Health Sciences’ decline.